KBC Group NV Acquires 23,582 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

KBC Group NV increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 12.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 207,840 shares of the company's stock after purchasing an additional 23,582 shares during the quarter. KBC Group NV's holdings in GE HealthCare Technologies were worth $16,249,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of GEHC. Union Bancaire Privee UBP SA acquired a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $280,000. Blue Trust Inc. raised its position in GE HealthCare Technologies by 21.4% during the fourth quarter. Blue Trust Inc. now owns 2,834 shares of the company's stock valued at $222,000 after acquiring an additional 500 shares in the last quarter. Cathy Pareto & Associates Inc. acquired a new position in GE HealthCare Technologies in the fourth quarter valued at approximately $670,000. Kingswood Wealth Advisors LLC boosted its position in GE HealthCare Technologies by 49.8% in the 4th quarter. Kingswood Wealth Advisors LLC now owns 6,813 shares of the company's stock worth $533,000 after purchasing an additional 2,265 shares in the last quarter. Finally, Embree Financial Group purchased a new position in shares of GE HealthCare Technologies during the 4th quarter valued at approximately $209,000. Hedge funds and other institutional investors own 82.06% of the company's stock.

Insider Activity at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the firm's stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock traded down $1.25 during trading hours on Friday, reaching $88.30. 1,775,473 shares of the stock were exchanged, compared to its average volume of 2,532,013. GE HealthCare Technologies Inc. has a 52-week low of $72.52 and a 52-week high of $94.55. The stock has a market cap of $40.34 billion, a P/E ratio of 24.26, a P/E/G ratio of 2.90 and a beta of 1.11. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The firm's 50 day moving average is $82.87 and its 200 day moving average is $85.02.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. During the same period in the previous year, the firm earned $0.99 EPS. The business's revenue was up .9% on a year-over-year basis. Analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This is a positive change from GE HealthCare Technologies's previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a yield of 0.16%. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies's dividend payout ratio is presently 3.85%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their target price for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company increased their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $96.00.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.